Bio-Rad Laboratories/BIO

$300.45

-3.66%
-
1D1W1MYTD1YMAX

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Ticker

BIO

Sector

Healthcare

Trading on

NYSE

Industry

Scientific & Technical Instr.

CEO

Norman Schwartz

Employees

8,030

Headquarters

Hercules, United States

BIO Metrics

BasicAdvanced
$10.62B
Market cap
-
P/E ratio
-$21.49
EPS
0.89
Beta
-
Dividend rate
$10.62B
0.89167
$494.05
$261.59
200.42K
5.831
4.338
13.717
13.723
0.31%
-4.94%
-6.94%
-5.16%
3.975
1.017
1.326
48.654
-4.67%
82.28%
1.62%

What the Analysts think about BIO

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 5 analysts.
36.4% upside
High $474.00
Low $350.00
$300.45
Current price
$409.80
Average price target

BIO Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
51.34% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$681.1M
7.75%
Net income
$349.7M
229.28%
Profit margin
51.34%
205.6%

BIO Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.05%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$3.34
$3.00
$2.33
$3.10
-
Expected
$3.54
$2.68
$2.78
$2.82
$2.15
Surprise
-5.7%
11.99%
-16.26%
10.05%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Bio-Rad Laboratories stock?

Bio-Rad Laboratories (BIO) has a market cap of $10.62B as of April 14, 2024.

What is the P/E ratio for Bio-Rad Laboratories stock?

The price to earnings (P/E) ratio for Bio-Rad Laboratories (BIO) stock is 0 as of April 14, 2024.

Does Bio-Rad Laboratories stock pay dividends?

No, Bio-Rad Laboratories (BIO) stock does not pay dividends to its shareholders as of April 14, 2024.

When is the next Bio-Rad Laboratories dividend payment date?

Bio-Rad Laboratories (BIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Bio-Rad Laboratories?

Bio-Rad Laboratories (BIO) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Bio-Rad Laboratories stock price target?

The target price for Bio-Rad Laboratories (BIO) stock is $409.8, which is 36.4% above the current price of $300.45. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Bio-Rad Laboratories stock

Buy or sell Bio-Rad Laboratories stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing